Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

In re Wellbutrin Direct Purchaser Antitrust Litigation

A class action antitrust suit accused GlaxoSmithKline of using monopolistic tactics against generic drug manufacturers to boost profits from its antidepressant drug Wellbutrin. The plaintiffs, direct purchasers of the drug, claimed that GSK devised a plan to keep Wellbutrin prices high by making fraudulent assertions to the U.S. Patent and Trademark Office and by engaging in sham patent litigation against generic drug manufacturers to keep a generic version of Wellbutrin from coming to market. In 2011, GSK agreed to settle the lawsuit for $49 million (plus up to $500,000 to cover the costs of notifying the class and administering the settlement).

Misconduct Type
Antitrust
Enforcement Agency
Non-Governmental
Contracting Party
None
Court Type
Civil
Disposition
Settlement
Date of Class Certification
5/2/2008
Contractors Involved Penalty
Total
GlaxoSmithKline $49,500,000
Further Information Released
Order Granting Class Certification 5/2/2008

Federal Contractor Misconduct Database